Here the authors generate mouse models of Tp53- and Atm-defective CLL mimicking the high-risk form of human disease and show that Atm-deficient CLL is sensitive to PARP1 inhibition. The gene discussed is ATM; the disease is B-cell chronic lymphocytic leukemia.